Transaction #20650 · Form 4 · 0001364846-25-000007
ImmunityBio, Inc. · Stock award · Stock Option (right to buy)
ImmunityBio, Inc. · Transacted December 12, 2025 · Filed December 16, 2025
What does this filing report?
An SEC Form 4 filing for ImmunityBio, Inc. records a stock award involving Stock Option (right to buy) on December 12, 2025. The reported quantity was 146,020. The filing date is December 16, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ImmunityBio, Inc.
- Company CIK
- 0001326110
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 146,020
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 146,020
- Ownership description
- Not reported
- SEC acceptance time
- Dec 16, 2025, 5:55 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Wendel Bruce ↗
Director
CIK 0001364846
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 146,020
- Conversion / exercise price
- 2.36
- Exercise date
- Not reported
- Expiration date
- December 12, 2035
Filing footnotes & remarks
- F1
- Subject to the reporting person's continuing to be a Service Provider (as defined in the 2025 Equity Incentive Plan) through each applicable vesting date, 48,673 of the shares subject to the award will vest on December 12, 2026, 48,673 of the shares subject to the award will vest on December 12, 2027 and 48,674 of the shares subject to the award will vest on December 12, 2028, such that the award will be fully vested on December 12, 2028; provided that, notwithstanding the foregoing, any unvested shares subject to the award will fully vest immediately prior to a Change in Control (as defined in the 2025 Equity Incentive Plan), subject to the reporting person continuing to be a Service Provider through the date of such Change in Control.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.